These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25485735)

  • 1. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
    Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
    JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.
    Chen JY; Ren Y; Yan P; Belina ME; Chung RT; Butt AA
    J Viral Hepat; 2018 Jul; 25(7):825-833. PubMed ID: 29478294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus.
    Xu F; Moorman AC; Tong X; Gordon SC; Rupp LB; Lu M; Teshale EH; Spradling PR; Boscarino JA; Trinacty CM; Schmidt MA; Holmberg SD; ; Holmberg SD; Teshale EH; Spradling PR; Moorman AC; Xing J; Tong X; Xu F; Gordon SC; Nerenz DR; Lu M; Lamerato L; Wang Y; Rupp LB; Akkerman N; Oja-Tebbe N; Zhang T; Li J; Sitarik A; Larkin D; Boscarino JA; Daar ZS; Curry PJ; Smith RE; Vijayadeva V; Parker JV; Schmidt MA; Donald JL; Keast EM
    Clin Infect Dis; 2016 Feb; 62(3):289-297. PubMed ID: 26417034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
    Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
    Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Martin DJ; Weideman R; Crook T; Brown G
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):181-6. PubMed ID: 26566061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
    Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
    PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatitis C virus infection in a large national seroconversion cohort in the direct-acting antiviral agent era: Results from ERCHIVES.
    Butt AA; Yan P;
    J Viral Hepat; 2021 Jun; 28(6):916-924. PubMed ID: 33763947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
    PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
    Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
    Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.